Sdk 12B-5 is a a novel antitumor agent. Maximum chemotherapeutic effect is obtained when SDK-12B-5 is administered p.o. repeatedly with every other day to avoid the cumulative toxicity.
PROMPT×
PROMPT
The What'sApp is temporarily not supported in mainland China
